跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
6-Methylpurine
首页
药物
6-Methylpurine
Experimental
Small Molecule
6-Methylpurine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
6
H
6
N
4
CAS 编号
2004-03-7
UNII ID
SEO6WX0OZG
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
US 8492420 B2
申请人: BECQ FREDERIC
优先权: 2004
US
2 件公开
Multiple crystal forms of istradefylline
CN 103554109 A
申请人: NANJING HUAWE MEDICINE TECHNOLOGY DEV CO LTD
优先权: 2013
CN
Synthetic method of medical body 2,3-dibromo-5-methylpurine-6-carboxylic ethyl ester
CN 106543183 A
申请人: WUXI QIANHAO BIOPHARMA CO LTD
优先权: 2016
CN
Medicine intermediate 2-chlorine-4-methoxy-5-methyl purine synthetic method
CN 106518877 A
申请人: WUXI QIANHAO BIOPHARMA CO LTD
优先权: 2016
CN
1-methylpurine-4-methyleneandrostane-triazole derivative, synthesis method and application thereof
CN 109293727 A
申请人: UNIV ZHENGZHOU
优先权: 2018
CN
Preparation method of Istradafylline
CN 118791491 A
申请人: STANDARD MEDICINE STANDARD MATERIAL RES AND DEVELOPMENT HUBEI CO LTD
优先权: 2024
CN
药物
反馈